Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients.
Mustacchi G, Puglisi F, Molino AM, Crivellari D, Ghiotto C, Ferro A, Brunello A, Saracchini S, Turazza M, Cretella E, Iop A, Malagoli M, Stefani M.
Mustacchi G, et al. Among authors: turazza m.
Future Oncol. 2015;11(10):1493-500. doi: 10.2217/fon.15.34. Epub 2015 Feb 24.
Future Oncol. 2015.
PMID: 25708426